Saturday, November 24, 2012

Google Alert - pharmaceutical news

News2 new results for pharmaceutical news
 
Quebec's plan to nurse Montreal's battered pharmaceutical sector back to health
Globe and Mail
Starting from the best projects put forward by universities and research centres, it will develop promising molecules to a stage where pharmaceutical companies would acquire them, explains Mr. Walker, NéoMed's chief scientific officer. Unveiled ...
See all stories on this topic »

Globe and Mail
Why MAP Pharmaceutical Shares Popped
Motley Fool
What: Shares of development-stage drug company MAP Pharmaceutical (Nasdaq: MAPP ) jumped as high as 20% today, after its New Drug Application resubmission for Levadex was accepted by the FDA. So what: The FDA's ruling helps pave the way for ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost